Month: April 2022

Dapagliflozin represent the class of drugs SGLT-2 inhibitors (Sodium Glucose Co-transporter-2 inhibitors). SGLT-2 inhibitors are newer class of oral hypoglycemic agents. Dapagliflozin got its FDA approval […]